Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Insulin Detemir in Alzheimer's Disease and MCI
NCT01547169Phase 2Completed
- Sponsor
- University of Washington
- Start
- Mar 2011
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin detemir in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by University of Washington. Started Mar 2011; status: completed.
02
Drugs
insulin detemir
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01547169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01547169.